Pharmacokinetic Interaction Between Tegoprazan and NSAIDs After Multiple Oral Dosing in Healthy Male Volunteers

Inclusion Criteria: * Healthy adult aged ≥ 19 and \< 55 year-old at screening * Body mass index (BMI) ≥ 19.0 kg/m2 and \< 27.0 kg/m2 with a body weight ≥ 55 kg at screening. Exclusion Criteria: * History or evidence of clinically significant disease * History of GI disease or surgery that may affect the absorption of a drug * Laboratory test result which falls into the following values( ALT or AST \> 2 × upper limit of normal (ULN)) * History of regular alcohol consumption exceeding 210 g/week within 6 months * Daily use of ≥ 20 cigarettes within 6 months * Has taken any investigational agent within 6 months prior to the first dose of IMP * Subjects who are considered ineligible to participate in this study at the discretion of the investigator.